Incidence of frailty and construction of prediction model in elderly male patients with chronic obstructive pulmonary disease

The incidence of frailty was studied and prediction model was constructed for the elderly male patients with chronic obstructive pulmonary disease (COPD). Total of 266 elderly males having COPD were selected, and Fried Frailty Phenotype was employed to investigate their frailty status. According to the clinical experience, literature and reports; age, BMI (Body Mass Index), course and condition of COPD, laboratory findings, lung function, life quality, nutritional status and disease acceptance were designated as independent variables; and the incidence of frailty was taken as dependent variable. A binary logistic regression model was applied to analyze the factors affecting incidence of frailty, and a prediction model was constructed for the clinical screening of elderly male COPD patients at high frailty risk. The scores of 266 elderly male COPD patients investigated by frailty phenotype (FP) phenotype ranged from 0 to 5, and mean score was 1.83 ± 0.43. Total of 103 patients scored more than 3 among these patients. The frailty detection rate was 38.72%. Multi-factors logistic regression analysis suggested that age, hospitalization for acute exacerbation of COPD within a year, and interleukin 6 (IL-6) levels were the risk factors for incidence of frailty in elderly male COPD patients, while FEV1 (Forced Expiratory Volume in 1 second) and MNA-SF (Mini Nutritional Assessment Short-Form) levels were the protective factors. COPD frailty was higher in elderly men. Age, inflammatory response, lung function, disease control and nutritional status were the independent factors affecting incidence of frailty. Strengthening the screening for frailty in elderly patients and monitoring their inflammatory response, lung function, and nutritional status were significant in reducing incidence and improving prognosis.

Elderly men; COPD; Frailty; Influencing factors; Prediction model

[1] Yang T, Chen R, Gu X, Xu J, Yang L, Zhao J, et al. Association of fine particulate matter air pollution and its constituents with lung function: the China pulmonary health study. Environment International. 2021; 156: 106707.

[2] GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023; 59: 101936.

[3] Kim-Dorner SJ, Schmidt T, Kuhlmann A, Graf von der Schulenburg JM, Welte T, Lingner H. Age- and gender-based comorbidity categories in general practitioner and pulmonology patients with COPD. NPJ Primary Care Respiratory Medicine. 2022; 32: 17.

[4] Siegfried JM. Sex and gender differences in lung cancer and chronic obstructive lung disease. Endocrinology. 2022; 163: bqab254.

[5] Antoniu SA, Boiculese LV, Prunoiu V. Frailty, a dimension of impaired functional status in advanced COPD: utility and clinical applicability. Medicina. 2021; 57: 474.

[6] Tarazona-Santabalbina FJ, Naval E, De la Cámara-de Las Heras JM, Cunha-Pérez C, Viña J. Is frailty diagnosis important in patients with COPD? A narrative review of the literature. International Journal of Environmental Research and Public Health. 2023; 20: 1678.

[7] Arellano-Orden E, Calero-Acuña C, Sánchez-López V, Carrasco-Hernández L, Márquez-Martín E, Ortega-Ruiz F, et al. Inflammatory response in human lung cells stimulated with plasma from COPD patients. Multidisciplinary Respiratory Medicine. 2022; 17: 817.

[8] David B, Bafadhel M, Koenderman L, De Soyza A. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax. 2021; 76: 188–195.

[9] Liu X, Hu Z, Zhou H. N-acetylcysteine improves inflammatory response in COPD patients by regulating Th17/Treg balance through hypoxia inducible factor-1α pathway. BioMed Research International. 2021; 2021: 1–7.

[10] Maguire D, Richards C, Woods M, Dolan R, Wilson Veitch J, Sim WMJ, et al. The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: comparison of 2 consecutive cohorts. PLOS ONE. 2021; 16: e0251924.

[11] Crisafulli E, Sartori G. A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD. J Bras Pneumol. 2021; 47: e20210389.

[12] Zhang H, Hu D, Xu Y, Wu L, Lou L. Effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Annals of Medicine. 2022; 54: 262–273.

[13] Daynes E, Gerlis C, Briggs-Price S, Jones P, Singh SJ. COPD assessment test for the evaluation of COVID-19 symptoms. Thorax. 2021; 76: 185–187.

[14] Corlateanu A, Mendez Y, Wang Y, Garnica RDJA, Botnaru V, Siafakas N. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”. Pulmonology. 2020; 26: 95–100.

[15] Konishi M. Scoring the physical frailty phenotype of patients with heart failure. Journal of Cachexia, Sarcopenia and Muscle. 2022; 13: 5–7.

[16] Kong L, Lyu Q, Yao H, Yang L, Chen S. The prevalence of frailty among community-dwelling older adults with diabetes: a meta-analysis. International Journal of Nursing Studies. 2021; 119: 103952.

[17] Tanaka T, Hirano H, Ohara Y, Nishimoto M, Iijima K. Oral Frailty Index-8 in the risk assessment of new-onset oral frailty and functional disability among community-dwelling older adults. Archives of Gerontology and Geriatrics. 2021; 94: 104340.

[18] Veronese N, Custodero C, Cella A, Demurtas J, Zora S, Maggi S, et al. Prevalence of multidimensional frailty and pre-frailty in older people in different settings: a systematic review and meta-analysis. Ageing Research Reviews. 2021; 72: 101498.

[19] Yuan L, Chang M, Wang J. Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: a systematic review and meta-analysis. Age and Ageing. 2021; 50: 1118–1128.

[20] Brighton LJ, Nolan CM, Barker RE, Patel S, Walsh JA, Polgar O, et al. Frailty and mortality risk in COPD: a cohort study comparing the fried frailty phenotype and short physical performance battery. International Journal of Chronic Obstructive Pulmonary Disease. 2023; 18: 57–67.

[21] Gephine S, Mucci P, Grosbois JM, Maltais F, Saey D. Physical frailty in COPD patients with chronic respiratory failure. International Journal of Chronic Obstructive Pulmonary Disease. 2021; 16: 1381–1392.

[22] Naval E, González MC, Giraldós S, Calatayud J, Jornet M, Lluch I, et al. Frailty assessment in a stable COPD cohort: is there a COPD-frail phenotype? COPD: Journal of Chronic Obstructive Pulmonary Disease. 2021; 18: 525–532.

[23] He D, Yan M, Zhou Y, Ge H, Zhang X, Xu Y, et al. Preserved ratio impaired spirometry and COPD accelerate frailty progression: evidence from a prospective cohort study. To be published in Chest. 2023. [Preprint].

[24] Arosio B, Ferri E, Mari D, Tobaldini E, Vitale G, Montano N. The influence of inflammation and frailty in the aging continuum. Mechanisms of Ageing and Development. 2023; 215: 111872.

[25] Watanabe N, Fujita Y, Nakayama J, Mori Y, Kadota T, Hayashi Y, et al. Anomalous epithelial variations and ectopic inflammatory response in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology. 2022; 67: 708–719.

[26] Qin T, Sheng W, Hu G. To analyze the influencing factors of senile coronary heart disease patients complicated with frailty syndrome. Journal of Healthcare Engineering. 2022; 2022: 1–6.

[27] Tsai C, Chang WP, Lin Y, Ho S, Lin Y. Physical frailty related to cognitive impairment and COPD exacerbation: a cross-sectional study. Respiratory Medicine. 2023; 208: 107129.

[28] Morita AA, Munhoz RF, Guzzi GL, Probst VS. Comparison of two frailty assessment methods and their association with functionality in subjects with exacerbation of COPD. Current Gerontology and Geriatrics Research. 2023; 2023: 6660984.